Overview
Watchlist
Equities
Crypto
Soon
Popular
Cookies
Terms of Service
Privacy Policy
Home
© 2025 FYStats 
Home
Equities
GANX
Fundamentals

Gain Therapeutics, Inc.

GANX

Chart
Fundamentals
Soon
Sentiment
Soon
Options

Revenue

55.18k
▲180.35k▲144.08%
3 Months Change

Assets

12.12M
▼-2.24M▼-15.61%
3 Months Change

Liabilities

4.78M
▼-671.97k▼-12.32%
3 Months Change

Free Cash Flow

-4.23M
▼-1.77M▼-72.22%
12 Months Change

Revenue/Cost Of Revenue

Loading...

Net Profit/Loss

Loading...

Assets/Liabilities

Loading...

Cash Flows

Loading...

Earnings Per Share

Loading...

Outstanding Shares

Loading...

Recent Quarterly and Annual Filings

2024-10-21
Form 8-K
ID: 0001104659-24-110287
2024-10-08
Form 8-K
ID: 0001104659-24-107052
2024-09-06
Form 8-K
ID: 0001104659-24-097781
2024-08-08
Form 10-Q
ID: 0001558370-24-011589
2024-08-08
Form 8-K
ID: 0001558370-24-011585
2024-07-12
Form 8-K
ID: 0001104659-24-079601
2024-07-09
Form 8-K
ID: 0001104659-24-078600
2024-06-28
Form 8-K
ID: 0001104659-24-076341
2024-06-25
Form 8-K
ID: 0001104659-24-074822
2024-06-14
Form 8-K
ID: 0001104659-24-071801